Clinical Trial Update: NBI to Detect Post-RT Mucosal Residual NPC [NA]

View source ↗

Summary

The trial evaluated using narrow-band imaging (NBI) to detect residual mucosal disease after radiotherapy in nasopharyngeal carcinoma, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Pamela Youde Nethersole Eastern Hospital | Conditions: Nasopharyngeal Carcinoma | NA | Status: COMPLETED | Results posted: 2017-10-20